Immunomedics Inc (IMMU)

4.33
0.13 2.91
NASDAQ : Health Care
Prev Close 4.46
Open 4.51
Day Low/High 4.17 / 4.55
52 Wk Low/High 1.50 / 5.44
Volume 4.39M
Avg Volume 1.82M
Exchange NASDAQ
Shares Outstanding 106.00M
Market Cap 472.76M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

VenBio Sends Letter To Immunomedics Stockholders

VenBio Sends Letter To Immunomedics Stockholders

venBio Select Advisor LLC ("venBio"), the beneficial owner of approximately 9.

VenBio Responds To Immunomedics Announcement

VenBio Responds To Immunomedics Announcement

venBio Select Advisor LLC ("venBio"), the beneficial owner of approximately 9.

Commit To Buy Immunomedics At $3, Earn 21.7% Using Options

Commit To Buy Immunomedics At $3, Earn 21.7% Using Options

Investors eyeing a purchase of Immunomedics, Inc. stock, but tentative about paying the going market price of $3.85/share, might benefit from considering selling puts among the alternative strategies at their disposal.

VenBio Responds To Immunomedics' Postponement Of Annual Meeting

VenBio Responds To Immunomedics' Postponement Of Annual Meeting

venBio Select Advisor LLC ("venBio"), the beneficial owner of approximately 9.

VenBio Comments On Its Recent Nomination Of Four Highly-Qualified Candidates For Board Of Immunomedics, Inc.

VenBio Comments On Its Recent Nomination Of Four Highly-Qualified Candidates For Board Of Immunomedics, Inc.

venBio Select Advisor LLC ("venBio"), venBio's New York-based investment manager focused principally on publicly traded biotechnology companies, and the largest beneficial owner of Immunomedics, Inc.

Short Interest Decreases By 18.7% For IMMU

Short Interest Decreases By 18.7% For IMMU

The most recent short interest data has been released for the 10/14/2016 settlement date, which shows a 4,276,328 share decrease in total short interest for Immunomedics, Inc. , to 18,563,792, a decrease of 18.72% since 09/30/2016.

3 Stocks To Avoid

Sometimes you have to kiss some frogs to find a prince.

First Week of May 2017 Options Trading For Immunomedics (IMMU)

First Week of May 2017 Options Trading For Immunomedics (IMMU)

Investors in Immunomedics, Inc. saw new options begin trading this week, for the May 2017 expiration.